UK markets closed

Gilead Sciences, Inc. (GILD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
65.51+0.31 (+0.48%)
At close: 04:00PM EDT
65.31 -0.20 (-0.31%)
After hours: 06:45PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close65.20
Open65.32
Bid65.47 x 200
Ask65.51 x 200
Day's range64.97 - 65.89
52-week range64.63 - 87.87
Volume7,072,299
Avg. volume7,430,732
Market cap81.689B
Beta (5Y monthly)0.20
PE ratio (TTM)181.97
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield3.08 (4.72%)
Ex-dividend date14 Jun 2024
1y target estN/A
All
News
  • Business Wire

    Gilead Sciences to Present at Upcoming Investor Conferences

    FOSTER CITY, Calif., April 30, 2024--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:

  • Business Wire

    FDA Approves Biktarvy® Label Update With Data for Pregnant Adults With HIV

    FOSTER CITY, Calif., April 26, 2024--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the U.S. Food and Drug Administration (FDA) approved an updated label with additional data reinforcing the safety and efficacy profile of Biktarvy® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg tablets, B/F/TAF) to treat pregnant people with HIV-1 (PWH) with suppressed viral loads. These additional data stem from Study 5310, which evaluated the pharmacokinetics, safety and efficacy of

  • Business Wire

    Gilead Sciences Announces First Quarter 2024 Financial Results

    FOSTER CITY, Calif., April 25, 2024--Gilead Sciences, Inc. (Nasdaq: GILD) announced today its first quarter 2024 results of operations.